PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för 3-methyl-7H-xanthine. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

11 hits

Bibliografisk träff 2010-04-20

Purine substrate recognition by the nucleobase-ascorbate transporter signature motif in the YgfO xanthine permease: ASN-325 binds and ALA-323 senses substrate.

Georgopoulou E, Mermelekas G, Karena E, Frillingos S.

J Biol Chem · research support, non-u.s. gov't; research-article; journal article · DOI 10.1074/jbc.m110.120543

Bibliografisk träff 2010-04-01

Ultrafast dynamics show that the theophylline and 3-methylxanthine aptamers employ a conformational capture mechanism for binding their ligands.

Lee SW, Zhao L, Pardi A, Xia T.

Biochemistry · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1021/bi100106c

Bibliografisk träff 2008-07-11

Paraxanthine, the primary metabolite of caffeine, provides protection against dopaminergic cell death via stimulation of ryanodine receptor channels.

Guerreiro S, Toulorge D, Hirsch E, Marien M, Sokoloff P, Michel PP.

Mol Pharmacol · journal article · DOI 10.1124/mol.108.048207

Bibliografisk träff 2006-07-25

Caffeine metabolites are inhibitors of the nuclear enzyme poly(ADP-ribose)polymerase-1 at physiological concentrations.

Geraets L, Moonen HJ, Wouters EF, Bast A, Hageman GJ.

Biochem Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bcp.2006.06.023

Bibliografisk träff 2004-01-01

Effect of St. John's wort on the pharmacokinetics of theophylline in healthy volunteers.

Morimoto T, Kotegawa T, Tsutsumi K, Ohtani Y, Imai H, Nakano S.

J Clin Pharmacol · clinical trial; research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1177/0091270003261496

Bibliografisk träff 2001-11-01

Fluvoxamine-theophylline interaction: gap between in vitro and in vivo inhibition constants toward cytochrome P4501A2.

Yao C, Kunze KL, Kharasch ED, Wang Y, Trager WF, Ragueneau I, Levy RH.

Clin Pharmacol Ther · clinical trial; research support, u.s. gov't, p.h.s.; randomized controlled trial; journal article · DOI 10.1067/mcp.2001.119724

Bibliografisk träff 1999-07-01

Potentiation of cADPR-induced Ca(2+)-release by methylxanthine analogues.

Cavallaro RA, Filocamo L, Galuppi A, Galione A, Brufani M, Genazzani AA.

J Med Chem · journal article · DOI 10.1021/jm980469t

Bibliografisk träff 1998-07-01

Effects of DU-6859a, a new quinolone antimicrobial, on theophylline metabolism in in vitro and in vivo studies.

Niki Y, Itokawa K, Okazaki O.

Antimicrob Agents Chemother · controlled clinical trial; clinical trial; research-article; journal article · DOI 10.1128/aac.42.7.1751

Bibliografisk träff 1998-02-01

Structural basis for specificity and potency of xanthine derivatives as activators of the CFTR chloride channel.

Chappe V, Mettey Y, Vierfond JM, Hanrahan JW, Gola M, Verrier B, Becq F.

Br J Pharmacol · research support, non-u.s. gov't; research-article; journal article · DOI 10.1038/sj.bjp.0701648

Bibliografisk träff 1997-03-01

Structure-activity relationship of xanthines and skeletal muscle ryanodine receptor/Ca2+ release channel.

Liu W, Meissner G.

Pharmacology · research support, u.s. gov't, p.h.s.; journal article · DOI 10.1159/000139480

Bibliografisk träff 1995-01-01

Inhibition kinetics of theophylline metabolism by mexiletine and its metabolites.

Ogiso T, Iwaki M, Uno S.

Biol Pharm Bull · journal article · DOI 10.1248/bpb.18.75